Jitendra Wadhane insider trades
Open-market stock purchases and sales by Jitendra Wadhane, Prin Fin & Acct Officer at Pyxis Oncology, Inc, from SEC Form 4 filings since Mar 24, 2023.
Track record: 0% of 1 scored buy are up 5% or more since purchase, averaging -6%.
Companies traded
- PYXS Pyxis Oncology, Inc: 3 buys, last Mar 24, 2026